Frontiers in Immunology (May 2022)

T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles

  • Luca Hensen,
  • Patricia T. Illing,
  • Louise C. Rowntree,
  • Jane Davies,
  • Adrian Miller,
  • Steven Y. C. Tong,
  • Steven Y. C. Tong,
  • Steven Y. C. Tong,
  • Jennifer R. Habel,
  • Carolien E. van de Sandt,
  • Carolien E. van de Sandt,
  • Katie L. Flanagan,
  • Katie L. Flanagan,
  • Katie L. Flanagan,
  • Katie L. Flanagan,
  • Anthony W. Purcell,
  • Katherine Kedzierska,
  • E. Bridie Clemens

DOI
https://doi.org/10.3389/fimmu.2022.812393
Journal volume & issue
Vol. 13

Abstract

Read online

CD8+ T cells are a pivotal part of the immune response to viruses, playing a key role in disease outcome and providing long-lasting immunity to conserved pathogen epitopes. Understanding CD8+ T cell immunity in humans is complex due to CD8+ T cell restriction by highly polymorphic Human Leukocyte Antigen (HLA) proteins, requiring T cell epitopes to be defined for different HLA allotypes across different ethnicities. Here we evaluate strategies that have been developed to facilitate epitope identification and study immunogenic T cell responses. We describe an immunopeptidomics approach to sequence HLA-bound peptides presented on virus-infected cells by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Using antigen presenting cell lines that stably express the HLA alleles characteristic of Indigenous Australians, this approach has been successfully used to comprehensively identify influenza-specific CD8+ T cell epitopes restricted by HLA allotypes predominant in Indigenous Australians, including HLA-A*24:02 and HLA-A*11:01. This is an essential step in ensuring high vaccine coverage and efficacy in Indigenous populations globally, known to be at high risk from influenza disease and other respiratory infections.

Keywords